Utrecht, Netherlands, June 7, 2023 /PRNewswire/ — Single Cell Discoveries, a contract research organization (CRO) dedicated to single cell sequencing, is proud to announce the first delivery of the new Illumina NovaSeq This landmark achievement reinforces Single Cell Discoveries’ commitment to driving innovation and delivering high-impact insights to biopharma companies, health systems and academic research centers globally.
The Illumina NovaSeq NovaSeq can produce more than 20,000 whole genomes per year at a cost $ 200 For each genome.
Mauro Moraro, CEO of Single Cell Discoveries, expresses his enthusiasm for the delivery, saying: “We are thrilled to integrate the Illumina NovaSeq “With the NovaSeq X Plus system, we are now better equipped than ever to ensure fast turnaround times and excellent quality throughout the single-cell workflow.”
“Our NovaSeq X series can provide 2.5 times greater throughput while also lowering sequencing costs,” he said. Bas Verhoefhead of Europe, Illumina. “Our revolutionary technology can enhance the ability of single-cell detection to provide rapid turnaround times and process large volumes of samples.”
Single Cell Discoveries’ investment in the Illumina NovaSeq By harnessing the power of this cutting-edge technology, Single Cell Discoveries aims to accelerate the development of precision medicine, contribute to the understanding of complex diseases, and advance groundbreaking research initiatives around the world. Europe And beyond.
About single cell discoveries
Single Cell Discoveries is a CRO dedicated to single-cell sequencing, providing high-impact insights to biopharma companies, health systems and academic research centers globally. Founded in 2018 by Mauro MoraroPhD, and Judith Fifi, MA, are based in Utrecht, Netherlands. To learn more, visit our website and connect with us on LinkedIn and Twitter.
Logo – https://mma.prnewswire.com/media/1605430/Single_Cell_Discoveries_Logo.jpg
Source: Single Cell Discoveries
